跳至主要内容
临床试验/PACTR202307828402450
PACTR202307828402450尚未招募3 期

The Impact of a combination of the RTS,S/AS01E Malaria Vaccibe and Perennial Malaria Chemoprevention in Ghanaian Children

PATH0 个研究点目标入组 2,310 人开始时间: 2023年5月15日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
PATH
入组人数
2,310

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • 1. Provision of a signed and dated informed consent form by a parent or guardian.
  • 2. A statement by the parent or guardian of a willingness to comply with all study procedures and of their availability for the duration of the study.
  • 3. Aged 14 - 18 weeks at enrollment.
  • 4. The infant is in good general health as evidenced by their medical history and by a physical examination.
  • 5. The infant is able to take oral medication.

排除标准

  • 1. Current use of a disallowed concomitant medications.
  • 2. Current participation in another intervention trial.
  • 3. Prior administration of a malaria vaccine.
  • 4. Known allergic reactions to components of SP, AQ or to RTSS/AS01 E .
  • 5. Any other condition(s) or diagnosis, or physical examination finding that precludes participation
  • as assessed by a study clinician.

研究者

发起方
PATH

相似试验